HeyJaredThe Drugs.com Monthly Update Podcast
The "Monthly Update" Podcast from Drugs.com delivers monthly roundups of new drug approvals, updated indications, safety alerts, and the latest healthcare news.
- Indexed episodes, last 90 days
- 2
- Latest publication
- Aug 3, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 3, 2026
Latest episodes
Drugs.com - Monthly Update July 2026 (opens the original)
Read excerpt
This July 2026 Drugs.com Monthly Update covers several new FDA approvals that provide novel treatment options and expand therapeutic possibilities. Gwyn Lo (ethinyl estradiol and norelgestromin): A new once-weekly transdermal patch providing low-dose estrogen and progestin for pregnancy prevention. Lytenava (bevacizumab-vikg): The first FDA-approved ophthalmic formulation of bevacizumab for patients with wet age-related macular degeneration. Simtriyo (centanafadine): A novel triple reuptake inhi
Drugs.com - Monthly Update June 2026 (opens the original)
Read excerpt
This month, we're exploring advances across multiple therapeutic areas. We cover Lumvoa for thyroid eye disease, Utebzi for complicated urinary tract infections, and Tregzi for blood cancers. Lumvoa (veligrotug-vvze): Approved for thyroid eye disease, Lumvoa is an IGF-1R inhibitor that offers significant improvements in TED symptoms, with notable early effectiveness. Utebzi (tebipenem pivoxil): The first oral carbapenem approved in the U.S., providing a new option for treating complicated urinar
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.